At present, surrogate definitions of breast cancer subtypes are based on immunohistochemical measurements of the expression of estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), with in situ hybridization confirmation where appropriate, and on the assessment of the proliferation index. The gene discussed is ERBB2; the disease is breast cancer.